Tobacco Use Disorder Clinical Trials
Tobacco Use Disorder clinical trials evaluate new treatments, behavioral therapies, and medications for tobacco Use Disorder. Corterve compiles actively recruiting Tobacco Use Disorder studies from the ClinicalTrials.gov registry so you can search by location and eligibility criteria. Participation is always voluntary and confidential. This information is educational and not medical advice — talk with a licensed clinician about whether a study is right for you.
Recruiting Tobacco Use Disorder studies
- Project Q: Cue-based Treatment Intervention to Promote Cessation Among People Who Smoke Lightly or Non-dailyNCT07425119NADuke UniversityDurham, North Carolina
- Oral Cannabidiol for Tobacco CessationNCT05445804PHASE1Johns Hopkins UniversityBaltimore, Maryland
- Nicotine Regulation for Dual Users of E-cigarettes and CigarettesNCT06614504PHASE2University of VermontProvidence, Rhode Island
- 5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use DisorderNCT05452772PHASE2Johns Hopkins UniversityBirmingham, Alabama
- Beta-Adrenergic Modulation of Drug Cue ReactivityNCT05587361PHASE4University of OklahomaTulsa, Oklahoma
- Examining the Effects of Cytisinicline on Neural Substrates of Cigarette Cue-reactivityNCT06617312PHASE2University of California, Los AngelesLos Angeles, California
- Contingency Management for Veteran Smokers Undergoing Major Elective SurgeryNCT06678672NAUniversity of California, San FranciscoSan Francisco, California
- Cannabis-Tobacco Co-Use Treatment StudyNCT06883162PHASE3Medical University of South CarolinaCharleston, South Carolina
- Smoking Cessation Behavioral Treatment StudyNCT03948893NAUniversity of Missouri-ColumbiaColumbia, Missouri
- An fMRI Study of the Effects of Clavulanic Acid on Drug AddictionNCT03713424PHASE2University of Missouri-ColumbiaColumbia, Missouri
- Multilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Among African AmericansNCT07576595NALouisiana State University Health Sciences Center in New OrleansNew Orleans, Louisiana
- Neuroimaging Correlates and Feasibility of Transcranial Magnetic Stimulation (TMS) to Improve Smoking Cessation Outcomes in Veterans With Comorbid PTSDNCT05723588PHASE2VA Office of Research and DevelopmentDurham, North Carolina
Tobacco Use Disorder trials by state
Tobacco Use Disorder trials by metro
Frequently asked questions
- How do I find recruiting Tobacco Use Disorder clinical trials?
- Corterve aggregates actively recruiting Tobacco Use Disorder studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
- Are Tobacco Use Disorder clinical trials free to join?
- Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
- Who can take part in a Tobacco Use Disorder clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.